Overview

Quality Assurance of Administering Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - QUMEA

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Investigation of efficacy of high-dose extended-release Methylphenidate in adults with ADHD, compared with a placebo
Phase:
Phase 3
Details
Lead Sponsor:
Medice Arzneimittel Pütter GmbH & Co KG
Treatments:
Central Nervous System Stimulants
Methylphenidate